Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)

LESSONS LEARNED: The combination of carotuximab with axitinib did not provide a benefit over axitinib monotherapy in patients with metastatic clear cell renal cell carcinoma who had previously progressed on one or more vascular endothelial growth factor (VEGF)‐targeted therapies. Exploratory evaluat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Choueiri, Toni K., Zakharia, Yousef, Pal, Sumanta, Kocsis, Judit, Pachynski, Russell, Poprach, Alexandr, Nixon, Andrew B., Liu, Yingmiao, Starr, Mark, Lyu, Jing, Owzar, Kouros, deShazo, Mollie, Lara, Primo, Geczi, Lajos, Ho, Thai H., Walsh, Meghara, Adams, Bonne, Robertson, Liz, Darif, Mohamed, Theuer, Charles, Agarwal, Neeraj
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Assuntos:
Clinical Trial Results
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265348/
https://ncbi.nlm.nih.gov/pubmed/33829609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13777
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares